26F7 Knudsen, Karen E. - Thomas Jefferson University - Thomas Jefferson University

Karen E. Knudsen, PhD

Contact Dr. Knudsen

Kimmel Cancer Center
233 S. Tenth Street, Suite 1008
Philadelphia, PA 19107

(215) 503-8574

Most Recent Peer-reviewed Publications

  1. Downregulation of critical oncogenes by the selective SK2 Inhibitor ABC294640 hinders prostate cancer progression
  2. Novel actions of next-generation taxanes benefit advanced stages of prostate cancer
  3. Cell-cycle-dependent regulation of androgen receptor function
  4. Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
  5. Consequence of the tumor-associated conversion to cyclin D1b
  6. Models of neuroendocrine prostate cancer
  7. Hormone whodunit: Clues for solving the case of intratumor androgen production
  8. The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness
  9. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
  10. Practical guide to the use of radium 223 dichloride
  11. PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer
  12. Androgen receptor regulation of prostate cancer progression and metastasis
  13. Transcriptional roles of PARP1 in cancer
  14. Commentary : Fusing transcriptomics to progressive prostate cancer
  15. Beyond DNA repair: DNA-PK function in cancer
  16. AR function in promoting metastatic prostate cancer
  17. Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells
  18. Targeting PARP-1 allosteric regulation offers therapeutic potential against cancer
  19. AMPed up to treat prostate cancer: Novel AMPK activators emerge for cancer therapy
  20. USP22 regulates oncogenic signaling pathways to drive lethal cancer progression